J Pediatric Infect Dis Soc. 2024 Aug 16:piae080. doi: 10.1093/jpids/piae080. Online ahead of print.
ABSTRACT
Post-artesunate delayed hemolysis (PADH) occurred in 6 of 24 children treated with artesunate for severe malaria in the United States; however severe hemolysis requiring hospitalization or transfusion was rare. In children in the U.S. treated with artesunate, counseling and symptom monitoring may be preferred to weekly laboratory surveillance for PADH.
PMID:39149792 | DOI:10.1093/jpids/piae080
